Filler BMJ updates

Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosis

BMJ 2007; 335 doi: (Published 05 July 2007) Cite this as: BMJ 2007;335:36


Research question Is once yearly intravenous zoledronic acid an effective treatment for postmenopausal osteoporosis?

Answer Yes. Yearly treatment prevents fractures and increases bone mineral density compared with a placebo.

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial